Uniprot AC Entrez ID Gene Name Disease Cell Type PTM Type State Position PMID P35499 6329 SCN4A Myopia Phosphorylation N T457 P35499 6329 SCN4A Congenital myopathy Phosphorylation N Y1074 P35499 6329 SCN4A Breast invasive carcinoma N-linked glycosylation N N1205 P35499 6329 SCN4A Hyperkalemic periodic paralysis N-linked glycosylation N N1205 P35499 6329 SCN4A Paramyotonia congenita Acetylation N K1318 P35499 6329 SCN4A Hyperkalemic periodic paralysis Phosphorylation N Y1715 P35499 6329 SCN4A Lung adenocarcinoma Phosphorylation N Y1715 P35523 1180 CLCN1 CLC1 Melanoma SUMOylation N K195 P35523 1180 CLCN1 CLC1 Myopia SUMOylation N K195 P35523 1180 CLCN1 CLC1 Pheochromocytoma and Paraganglioma SUMOylation N K195 P35523 1180 CLCN1 CLC1 Skin cutaneous melanoma SUMOylation N K195 P35523 1180 CLCN1 CLC1 Myopia Phosphorylation N T636 P35523 1180 CLCN1 CLC1 Myopia Phosphorylation N S642 P35523 1180 CLCN1 CLC1 Myopia Phosphorylation N S645 P35523 1180 CLCN1 CLC1 Myopia Phosphorylation N S707 P35523 1180 CLCN1 CLC1 Lung adenocarcinoma Phosphorylation N T891 P35523 1180 CLCN1 CLC1 Sarcoma Phosphorylation N T891 P35523 1180 CLCN1 CLC1 Stomach adenocarcinoma Phosphorylation N T891 P35523 1180 CLCN1 CLC1 Uterine corpus endometrial carcinoma Phosphorylation N T891 P35523 1180 CLCN1 CLC1 Lung adenocarcinoma Phosphorylation N S892 P35523 1180 CLCN1 CLC1 Sarcoma Phosphorylation N S892 P35523 1180 CLCN1 CLC1 Stomach adenocarcinoma Phosphorylation N S892 P35523 1180 CLCN1 CLC1 Uterine corpus endometrial carcinoma Phosphorylation N S892 P35523 1180 CLCN1 CLC1 Lung adenocarcinoma Phosphorylation N T893 P35523 1180 CLCN1 CLC1 Sarcoma Phosphorylation N T893 P35523 1180 CLCN1 CLC1 Stomach adenocarcinoma Phosphorylation N T893 P35523 1180 CLCN1 CLC1 Uterine corpus endometrial carcinoma Phosphorylation N T893 P35523 1180 CLCN1 CLC1 Myopia Phosphorylation N T929 Q8IVL5 55214 P3H2 LEPREL1 MLAT4 Esophageal adenocarcinoma Phosphorylation N S112 Q8IVL5 55214 P3H2 LEPREL1 MLAT4 Skin cutaneous melanoma Ubiquitination N K166 Q8IVL5 55214 P3H2 LEPREL1 MLAT4 Bladder urothelial carcinoma Ubiquitination N K208 Q8IVL5 55214 P3H2 LEPREL1 MLAT4 Skin cutaneous melanoma Ubiquitination N K208 Q8IVL5 55214 P3H2 LEPREL1 MLAT4 Breast invasive carcinoma Ubiquitination N K373 Q8IVL5 55214 P3H2 LEPREL1 MLAT4 Prostate adenocarcinoma Ubiquitination N K373 Q8IVL5 55214 P3H2 LEPREL1 MLAT4 Skin cutaneous melanoma Ubiquitination N K373 Q8IVL5 55214 P3H2 LEPREL1 MLAT4 Prostate adenocarcinoma Ubiquitination N K376 Q8IVL5 55214 P3H2 LEPREL1 MLAT4 Skin cutaneous melanoma Ubiquitination N K376 Q8IVL5 55214 P3H2 LEPREL1 MLAT4 Skin cutaneous melanoma Ubiquitination N K383 Q8IVL5 55214 P3H2 LEPREL1 MLAT4 Skin cutaneous melanoma Ubiquitination N K434 Q8IVL5 55214 P3H2 LEPREL1 MLAT4 Hepatocellular carcinoma Ubiquitination N K496 Q8IVL5 55214 P3H2 LEPREL1 MLAT4 Renal cell carcinoma Ubiquitination N K496 Q8IVL5 55214 P3H2 LEPREL1 MLAT4 Uterine corpus endometrial carcinoma Ubiquitination N K496 Q8IVL5 55214 P3H2 LEPREL1 MLAT4 Myopia Ubiquitination N K505 Q8IVL5 55214 P3H2 LEPREL1 MLAT4 Bladder urothelial carcinoma Ubiquitination N K513 Q8IVL5 55214 P3H2 LEPREL1 MLAT4 Myopia Ubiquitination N K513 Q8IVL5 55214 P3H2 LEPREL1 MLAT4 Transitional cell carcinoma Ubiquitination N K513 Q8IVL5 55214 P3H2 LEPREL1 MLAT4 Bladder urothelial carcinoma Ubiquitination N K516 Q8IVL5 55214 P3H2 LEPREL1 MLAT4 Transitional cell carcinoma Ubiquitination N K516 Q8IVL5 55214 P3H2 LEPREL1 MLAT4 Colon adenocarcinoma Ubiquitination N K635 Q8IVL5 55214 P3H2 LEPREL1 MLAT4 Thymoma Ubiquitination N K635 Q8IVL5 55214 P3H2 LEPREL1 MLAT4 Uterine carcinosarcoma Ubiquitination N K635 Q8IVL5 55214 P3H2 LEPREL1 MLAT4 Colon adenocarcinoma Ubiquitination N K637 Q8IVL5 55214 P3H2 LEPREL1 MLAT4 Thymoma Ubiquitination N K637 Q8IVL5 55214 P3H2 LEPREL1 MLAT4 Uterine carcinosarcoma Ubiquitination N K637 Q8IVL5 55214 P3H2 LEPREL1 MLAT4 Head and neck squamous cell carcinoma Ubiquitination N K655 Q8IVL5 55214 P3H2 LEPREL1 MLAT4 Skin cutaneous melanoma Ubiquitination N K655 Q8IVL5 55214 P3H2 LEPREL1 MLAT4 Stomach adenocarcinoma Ubiquitination N K705 Q9H582 84146 ZNF644 KIAA1221 ZEP2 Bladder urothelial carcinoma SUMOylation N K39 Q9H582 84146 ZNF644 KIAA1221 ZEP2 Stomach adenocarcinoma SUMOylation N K39 Q9H582 84146 ZNF644 KIAA1221 ZEP2 Breast cancer Phosphorylation N S50 Q9H582 84146 ZNF644 KIAA1221 ZEP2 Stomach adenocarcinoma Phosphorylation N S50 Q9H582 84146 ZNF644 KIAA1221 ZEP2 Breast adenocarcinoma Phosphorylation N T73 Q9H582 84146 ZNF644 KIAA1221 ZEP2 Prostate adenocarcinoma Phosphorylation N T73 Q9H582 84146 ZNF644 KIAA1221 ZEP2 Ovarian cancer Phosphorylation N S199 Q9H582 84146 ZNF644 KIAA1221 ZEP2 Hepatocellular carcinoma Phosphorylation N S309 Q9H582 84146 ZNF644 KIAA1221 ZEP2 Myopia Phosphorylation N S309 Q9H582 84146 ZNF644 KIAA1221 ZEP2 Rectum adenocarcinoma Phosphorylation N S309 Q9H582 84146 ZNF644 KIAA1221 ZEP2 Hepatocellular carcinoma SUMOylation N K319 Q9H582 84146 ZNF644 KIAA1221 ZEP2 Liver cancer SUMOylation N K319 Q9H582 84146 ZNF644 KIAA1221 ZEP2 Rectum adenocarcinoma SUMOylation N K319 Q9H582 84146 ZNF644 KIAA1221 ZEP2 Colon adenocarcinoma Ubiquitination N K369 Q9H582 84146 ZNF644 KIAA1221 ZEP2 Myopia Ubiquitination N K369 Q9H582 84146 ZNF644 KIAA1221 ZEP2 Lung adenocarcinoma Phosphorylation N S394 Q9H582 84146 ZNF644 KIAA1221 ZEP2 Myopia Phosphorylation N S398 Q9H582 84146 ZNF644 KIAA1221 ZEP2 Bladder urothelial carcinoma Ubiquitination N K485 Q9H582 84146 ZNF644 KIAA1221 ZEP2 Colon adenocarcinoma Ubiquitination N K485 Q9H582 84146 ZNF644 KIAA1221 ZEP2 Uterine corpus endometrial carcinoma Ubiquitination N K509 Q9H582 84146 ZNF644 KIAA1221 ZEP2 Cervical squamous cell carcinoma and endocervical adenocarcinoma Ubiquitination N K553 Q9H582 84146 ZNF644 KIAA1221 ZEP2 Colon adenocarcinoma Ubiquitination N K553 Q9H582 84146 ZNF644 KIAA1221 ZEP2 Lung adenocarcinoma Ubiquitination N K553 Q9H582 84146 ZNF644 KIAA1221 ZEP2 Lung squamous cell carcinoma Phosphorylation N S580 Q9H582 84146 ZNF644 KIAA1221 ZEP2 Uterine corpus endometrial carcinoma Phosphorylation N S580 Q9H582 84146 ZNF644 KIAA1221 ZEP2 Myopia Acetylation N K589 Q9H582 84146 ZNF644 KIAA1221 ZEP2 Stomach adenocarcinoma SUMOylation N K589 Q9H582 84146 ZNF644 KIAA1221 ZEP2 Uterine corpus endometrial carcinoma SUMOylation N K589 Q9H582 84146 ZNF644 KIAA1221 ZEP2 Stomach adenocarcinoma Ubiquitination N K589 Q9H582 84146 ZNF644 KIAA1221 ZEP2 Uterine corpus endometrial carcinoma Ubiquitination N K589 Q9H582 84146 ZNF644 KIAA1221 ZEP2 Stomach adenocarcinoma Phosphorylation N S599 Q9H582 84146 ZNF644 KIAA1221 ZEP2 Skin cutaneous melanoma Ubiquitination N K603 Q9H582 84146 ZNF644 KIAA1221 ZEP2 Stomach adenocarcinoma Ubiquitination N K603 Q9H582 84146 ZNF644 KIAA1221 ZEP2 Bladder urothelial carcinoma Phosphorylation N S673 Q9H582 84146 ZNF644 KIAA1221 ZEP2 Hepatocellular carcinoma Phosphorylation N S673 Q9H582 84146 ZNF644 KIAA1221 ZEP2 Myopia Phosphorylation N S673 Q9H582 84146 ZNF644 KIAA1221 ZEP2 Bladder urothelial carcinoma SUMOylation N K676 Q9H582 84146 ZNF644 KIAA1221 ZEP2 Hepatocellular carcinoma SUMOylation N K676 Q9H582 84146 ZNF644 KIAA1221 ZEP2 Myopia SUMOylation N K676 Q9H582 84146 ZNF644 KIAA1221 ZEP2 Bladder urothelial carcinoma Ubiquitination N K727 Q9H582 84146 ZNF644 KIAA1221 ZEP2 Bladder urothelial carcinoma SUMOylation N K733 Q9H582 84146 ZNF644 KIAA1221 ZEP2 Breast invasive carcinoma SUMOylation N K733 Q9H582 84146 ZNF644 KIAA1221 ZEP2 Bladder urothelial carcinoma Ubiquitination N K733 Q9H582 84146 ZNF644 KIAA1221 ZEP2 Breast invasive carcinoma Ubiquitination N K733 Q9H582 84146 ZNF644 KIAA1221 ZEP2 Bladder urothelial carcinoma Ubiquitination N K843 Q9H582 84146 ZNF644 KIAA1221 ZEP2 Glioblastoma multiforme Ubiquitination N K843 Q9H582 84146 ZNF644 KIAA1221 ZEP2 Stomach adenocarcinoma Ubiquitination N K843 Q9H582 84146 ZNF644 KIAA1221 ZEP2 Myopia Phosphorylation N S852 Q9H582 84146 ZNF644 KIAA1221 ZEP2 Cervical squamous cell carcinoma and endocervical adenocarcinoma Ubiquitination N K963 Q9H582 84146 ZNF644 KIAA1221 ZEP2 Head and neck squamous cell carcinoma Ubiquitination N K963 Q9H582 84146 ZNF644 KIAA1221 ZEP2 Leiomyosarcoma Ubiquitination N K963 Q9H582 84146 ZNF644 KIAA1221 ZEP2 Sarcoma Ubiquitination N K963 Q9H582 84146 ZNF644 KIAA1221 ZEP2 Colon adenocarcinoma Phosphorylation N S1000 Q9H582 84146 ZNF644 KIAA1221 ZEP2 Colon adenocarcinoma Phosphorylation N T1006 Q9H582 84146 ZNF644 KIAA1221 ZEP2 Breast adenocarcinoma Phosphorylation N T1020 Q9H582 84146 ZNF644 KIAA1221 ZEP2 Breast adenocarcinoma Ubiquitination N K1031 Q9H582 84146 ZNF644 KIAA1221 ZEP2 Colon adenocarcinoma SUMOylation N K1091 Q9H582 84146 ZNF644 KIAA1221 ZEP2 Myopia SUMOylation N K1091 Q9H582 84146 ZNF644 KIAA1221 ZEP2 Rectum adenocarcinoma SUMOylation N K1091 Q9H582 84146 ZNF644 KIAA1221 ZEP2 Colon adenocarcinoma SUMOylation N K1094 Q9H582 84146 ZNF644 KIAA1221 ZEP2 Lung adenocarcinoma SUMOylation N K1094 Q9H582 84146 ZNF644 KIAA1221 ZEP2 Rectum adenocarcinoma SUMOylation N K1094 Q9H582 84146 ZNF644 KIAA1221 ZEP2 Colon adenocarcinoma Ubiquitination N K1094 Q9H582 84146 ZNF644 KIAA1221 ZEP2 Lung adenocarcinoma Ubiquitination N K1094 Q9H582 84146 ZNF644 KIAA1221 ZEP2 Myopia Ubiquitination N K1094 Q9H582 84146 ZNF644 KIAA1221 ZEP2 Rectum adenocarcinoma Ubiquitination N K1094 Q9H582 84146 ZNF644 KIAA1221 ZEP2 Bladder urothelial carcinoma Ubiquitination N K1110 Q9H582 84146 ZNF644 KIAA1221 ZEP2 Bladder urothelial carcinoma Phosphorylation N S1114 Q9H582 84146 ZNF644 KIAA1221 ZEP2 Hepatocellular carcinoma Phosphorylation N S1114 Q9H582 84146 ZNF644 KIAA1221 ZEP2 Bladder urothelial carcinoma SUMOylation N K1157 Q9H582 84146 ZNF644 KIAA1221 ZEP2 Thyroid carcinoma SUMOylation N K1157 Q9H582 84146 ZNF644 KIAA1221 ZEP2 Thyroid carcinoma SUMOylation N K1165 Q9H582 84146 ZNF644 KIAA1221 ZEP2 Thyroid carcinoma Ubiquitination N K1165 Q9H582 84146 ZNF644 KIAA1221 ZEP2 Bladder urothelial carcinoma Ubiquitination N K1178 Q9H582 84146 ZNF644 KIAA1221 ZEP2 Lung adenocarcinoma Ubiquitination N K1178 Q9H582 84146 ZNF644 KIAA1221 ZEP2 Breast invasive carcinoma Phosphorylation N Y1259 Q9H582 84146 ZNF644 KIAA1221 ZEP2 Myopia Ubiquitination N K1282 O54851 14617 Gjd2 Gja9 Myopia Serine phosphorylation U S293 32547367